Testing antiviral CRISPR RNA therapeutics in human Organ Chips (IMAGE)

Wyss Institute for Biologically Inspired Engineering at Harvard

Testing antiviral CRISPR RNA therapeutics in human Organ Chips

Caption

The Wyss team designed a CRISPR RNA therapy able to broadly fight influenza A virus infection and a preclinical system to test it efficacy and safety in. The system, which utilizes human Organ Chip technology, can be applied to the future development and translation of such therapies and overcomes major limitations with animal models. 

Credit

Wyss Institute at Harvard University

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.